A significant association of SOX11 and N-CADHERIN (CDH2) expression is also observed in genomic analyses across six cancer types, suggesting that mesenchymal pathways may be activated by SOX11 in both normal and cancer cells (Vervoort et al., 2013). This evidence concerns the gene CDH2 and cancer.